【摘 要】
：
The study of respiratory plasticity in animal models spans decades. At the bench, researchers use an array of techniques aimed at harnessing the power of plasticity within the central nervous system to restore respiration following spinal cord injury. Thi
【机 构】
：
Department of Neurobiology&Anatomy,Drexel University,Philadelphia,PA,USA;Marion Murray Spinal Cord R
论文部分内容阅读
The study of respiratory plasticity in animal models spans decades. At the bench, researchers use an array of techniques aimed at harnessing the power of plasticity within the central nervous system to restore respiration following spinal cord injury. This field of research is highly clinically relevant. People living with cervical spinal cord injury at or above the level of the phrenic motoneuron pool at spinal levels C3–C5 typically have significant impairments in breathing which may require assisted ventilation. Those who are ventilator dependent are at an increased risk of ventilator-associated co-morbidities and have a drastically reduced life expectancy. Pre-clinical research examining respiratory plasticity in animal models has laid the groundwork for clinical trials. Despite how widely researched this injury is in animal models, relatively few treatments have broken through the preclinical barrier. The three goals of this present review are to define plasticity as it pertains to respiratory function post-spinal cord injury, discuss plasticity models of spinal cord injury used in research, and explore the shift from preclinical to clinical research. By investigating current targets of respiratory plasticity research, we hope to illuminate preclinical work that can influence future clinical investigations and the advancement of treatments for spinal cord injury.
其他文献
背景 卒中后抑郁(PSD)是卒中患者常见并发症之一,可增加卒中患者致残率、病死率,但其确切发病机制仍不明确.目的 通过弥散张量纤维束成像(DTT)观察PSD患者脑白质纤维束改变并分析其与抑郁的相关性.方法 选取2019年9月至2020年9月在锦州医科大学附属第一医院住院治疗的首发缺血性脑卒中患者40例,根据PSD发生情况分为PSD组和非PSD组,每组20例;选取同期在锦州医科大学附属第一医院体检的健康志愿者20例作为正常对照组.三组受试者均行DTT检查,比较三组受试者感兴趣区(ROI)各向异性分数(FA)
支气管哮喘是儿童最常见的慢性疾病,其漏诊率高,发病机制复杂.代谢组学通过定性定量分析生物样品的低分子量分子或代谢产物的变化,为寻找生物标志物和发病机制提供了一种新途径.本文综述了代谢组学技术运用于儿童哮喘的研究,运用靶向或非靶向研究策略,以哮喘儿童及健康儿童的血液、呼出气、粪便及尿液为研究对象,试图寻找儿童哮喘的潜在生物标志物及发病机制,为儿童哮喘的诊断及治疗提供帮助.近年来代谢组学在儿童哮喘方面取得了不小的进展,但受限于个体差异、样品采集、数据分析及组学异质性等因素,代谢组学在儿童哮喘的解释方面仍面临挑
胶质淋巴系统是一个由星形胶质细胞上水通道蛋白4(AQP4)介导的促进脑脊液(CSF)-组织液(ISF)交换流动的系统,起到维持CSF-ISF平衡及清除脑内代谢废物等作用.越来越多的证据显示胶质淋巴系统与脑卒中病理改变及转归密切相关.目前研究发现胶质淋巴系统对脑卒中后CSF循环及脑水肿的发生有一定影响,且对急性缺血性脑卒中、蛛网膜下腔出血、脑出血等不同类型的脑卒中的病理改变也有影响.本文就胶质淋巴系统的结构、功能及其对不同类型脑卒中病理变化影响的研究进展进行综述,为脑卒中的防治提供参考.
背景 有效评估脑卒中发生风险及尽早启动一级预防对于降低脑卒中发病率至关重要,而氧化三甲胺(TMAO)是一种近年被发现的肠道微生物代谢产物,其与脑卒中发生风险关系的研究尚少.目的 探究血清TMAO水平与缺血性脑卒中(AIS)发生风险的相关性.方法 2020年10—12月,基于脑卒中高危人群筛查和干预项目,于内蒙古自治区呼和浩特市新城区社区脑卒中筛查人群中随机抽取500例为研究对象,依据研究标准最终纳入399例.依据“中风”危险评分卡将研究对象分为正常对照组(n=121)、中危组(即AIS发生风险中危人群,n
短链脂肪酸(SCFAs)是一类含有1～6个碳原子的饱和脂肪酸,主要由肠道内特定菌群通过发酵膳食纤维产生,对维持肠道内环境稳态发挥重要作用.近年来研究表明SCFAs可调节糖脂代谢、调节能量平衡、维持肠道屏障、减轻炎性反应,并通过上述多途径参与2型糖尿病、肥胖、脂代谢紊乱、非酒精性脂肪性肝病等代谢性疾病的发生与发展.本文总结了SCFAs调控代谢的机制及其防治代谢性疾病的研究进展,旨在为代谢性疾病的防治提供更多参考资料.
Extracellular vesicles are composed of fragments of exfoliated plasma membrane, organelles or nuclei and are released after cell activation, apoptosis or destruction. Platelet-derived extracellular vesicles are the most abundant type of extracellular vesi
Graphene and graphene-based materials have the ability to induce stem cells to differentiate into neurons, which is necessary to overcome the current problems faced in the clinical treatment of spinal cord injury. This review summarizes the advantages of
The neuropsychiatric disease named obsessive-compulsive disorder is composed by obsessions and/or compulsions. Obsessive-compulsive disorder etiologies are undefined. However, numerous mechanisms in several localizations are implicated. Some studies showe
The incidence of neurodegenerative diseases is increasing due to changing age demographics and the incidence of sports-related traumatic brain injury is tending to increase over time. Currently approved medicines for neurodegenerative diseases only tempor
Cell-based models are a promising tool in deciphering the molecular mechanisms underlying the pathogenesis of neurological disorders as well as aiding in the discovery and development of future drug therapies. The greatest challenge is creating cell-based